Source: Annual Congress 2002 - Community- and hospital-acquired pneumonias: inflammatory mechanisms, epidemiology and therapy
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. Laserna, J. L. López-Campos, B. Romero, F. Rodríguez-Panadero, E. Barrot (Sevilla, Spain). D-Dimer as a marker of fibrinolytic activity in complicated parapneumonic effusions and empyema. Eur Respir J 2002; 20: Suppl. 38, 2669

Member's Comments

No comment yet.

Related content which might interest you: Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions Source: Eur Respir J 2002; 19: 320-325 Year: 2002 Efficacy of intrapleural streptokinase use in complicated parapneumonic pleural effusions and empyema Source: Annual Congress 2008 - Pleural effusion Year: 2008 Pleural fluid C-reactive protein concentration in discriminating uncomplicated from complicated parapneumonic pleural effusion Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 Role of C-reactive protein in discriminating complicated and uncomplicated parapneumonic effusion from malignant and tuberculous pleural effusion Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status Year: 2021 Procalcitonin in pleural fluid: A new tool for the diagnosis of empyema and parapneumonic pleural effusions? Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011 Parapneumonic effusion and empyema Source: Respipedia Article Year: 2017 Treatment results of patients with complicated parapneumonic effusion and empyema Source: Eur Respir J 2002; 20: Suppl. 38, 358s Year: 2002 Interelukin-17A is elevated in parapneumonic pleural effusions and is associated with neutrophils and VEGF Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006 Pleural fluid IL-6 levels in the identification of the complicated parapneumonic pleural effusion Source: Annual Congress 2008 - Pleural effusion Year: 2008 Respiratory functional status after intrapleural t-PA administration for complicated parapneumonic effusions Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012 Prognostic features of residual pleural thickening in parapneumonic pleural effusions Source: Eur Respir J 2003; 21: 952-955 Year: 2003 Update on the management of parapneumonic pleural effusions Source: Virtual Congress 2021 – Spanish/Portuguese programme 2021 Year: 2021 Late period pulmonary functions of the patients who were treated for parapneumonic effusion and empyema Source: Eur Respir J 2006; 28: Suppl. 50, 488s Year: 2006 Treatment of parapneumonic pleural effusion and empyema: conservative view Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=199 Year: 2004 Management of parapneumonic effusion and empyema in children Source: Eur Respir J 2002; 20: Suppl. 38, 589s Year: 2002 Diagnostic value of C-reactive protein in discrimination between complicated and uncomplicated parapneumonic effusion Source: International Congress 2019 – Clinical problems Year: 2019 Serum C-reactive protein levels predict the need for surgical intervention in patients with empyema/complicated parapneumonic pleural effusions Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019